Thomas Mathivet
-
- Axon Guidance and Neuronal Signaling 6
- Genetics top 5%
- Glioma Diagnosis and Treatment 5
- Cell Biology top 2%
- Zebrafish Biomedical Research Applications 5
- Neurology top 5%
- Molecular Biology top 5%
- Angiogenesis and VEGF in Cancer 13
-
- Immune cells in cancer 7
- Immune Cell Function and Interaction 5
- Galectins and Cancer Biology 4
-
- Lipid metabolism and disorders 4
- Co-authors
- Anne EichmannBruno LarrivéeHolger GerhardtClaudia PrahstAntónio DuarteJean‐Léon ThomasChristiane BréantEmma Gordon
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Thomas Mathivet
41 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Cellular and Molecular Neuroscience 600
- Genetics 339
- Cell Biology 463
- Neurology 214
- Molecular Biology 1.5k
Countries citing papers authored by Thomas Mathivet
This map shows the geographic impact of Thomas Mathivet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Mathivet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Mathivet more than expected).
Fields of papers citing papers by Thomas Mathivet
This network shows the impact of papers produced by Thomas Mathivet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Mathivet. The network helps show where Thomas Mathivet may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Mathivet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 13 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 1 | |
| 7 | 2019 | 58 | |
| 8 | 2019 | 100 | |
| 9 | 2019 | 67 | |
| 10 | Development and plasticity of meningeal lymphatic vesselsbreakdown → | 2017 | 315 |
| 11 | 2017 | 114 | |
| 12 | 2017 | 47 | |
| 13 | 2016 | 133 | |
| 14 | 2015 | 59 | |
| 15 | 2014 | 3 | |
| 16 | 2013 | 61 | |
| 17 | 2012 | 289 | |
| 18 | 2010 | 267 | |
| 19 | 2008 | 52 | |
| 20 | 2007 | 47 |
About Thomas Mathivet
Thomas Mathivet is a scholar working on Genetics, Immunology and Cell Biology, having authored 43 papers that have together received 3.1k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (13 papers), Immune cells in cancer (7 papers), Axon Guidance and Neuronal Signaling (6 papers), Glioma Diagnosis and Treatment (5 papers), Zebrafish Biomedical Research Applications (5 papers), Immune Cell Function and Interaction (5 papers), Lipid metabolism and disorders (4 papers) and Galectins and Cancer Biology (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (600 citations), Genetics (339 citations) and Cell Biology (463 citations). Thomas Mathivet has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Anne Eichmann, Bruno Larrivée, Holger Gerhardt, Claudia Prahst, António Duarte, Jean‐Léon Thomas, Christiane Bréant, Emma Gordon, Véronique Mathieu and Michael Simons. Their work appears in journals such as Nature Communications, Scientific Reports, Nature Medicine, Circulation Research and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.